Florian Oyen Selected Research

Florian Oyen Research Topics

Disease

13	Neoplasms (Cancer) 10/2021 - 12/2009
7	Rhabdoid Tumor (Rhabdoid Tumors) 10/2021 - 02/2010
6	Thrombotic Thrombocytopenic Purpura 01/2018 - 03/2003
4	Typical Teratoid Rhabdoid Tumor 01/2021 - 06/2011
3	von Willebrand Diseases (von Willebrand's Disease) 12/2014 - 07/2004
2	Type 3 von Willebrand Disease 10/2021 - 04/2013
2	Hemorrhage 10/2021 - 12/2006
2	Pathologic Complete Response 09/2014 - 12/2009
2	Brain Neoplasms (Brain Tumor) 02/2013 - 06/2011
2	Type 2 von Willebrand Disease 01/2013 - 06/2010
2	Hemophilia A (Haemophilia) 02/2011 - 12/2006
1	Glioblastoma (Glioblastoma Multiforme) 10/2021
1	Thrombosis (Thrombus) 01/2021
1	Rhabdoid Tumor Predisposition Syndrome 1 01/2021
1	Residual Neoplasm 01/2021
1	Thrombophilia 01/2021
1	Coffin-Siris syndrome 01/2018
1	Nicolaides Baraitser syndrome 01/2018
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2018
1	Infections 02/2017
1	Thrombocytopenia (Thrombopenia) 02/2017
1	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 12/2016
1	Neurofibroma 12/2016
1	Monosomy 12/2016
1	Neurilemmoma (Schwannoma) 12/2016
1	Infratentorial Neoplasms (Posterior Fossa Tumors) 01/2016
1	Neoplasm Metastasis (Metastasis) 09/2014
1	Anemia 03/2013
1	Body Weight (Weight, Body) 03/2013
1	Iron-Refractory Iron Deficiency Anemia 03/2013
1	Uniparental Disomy 02/2010
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 12/2009
1	Neuroectodermal Tumors (Neuroectodermal Tumor) 12/2009
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2006
1	Thromboembolism 12/2006
1	Evans Syndrome 03/2003
1	Hemolytic-Uremic Syndrome 03/2003
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2003

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 10/2021 - 12/2009
7	von Willebrand FactorIBA 10/2021 - 03/2003
4	thiamine triphosphorate (TTP)IBA 02/2017 - 03/2003
3	Metalloproteases (Metalloproteinases)IBA 01/2018 - 07/2006
3	Factor VIII (Coagulation Factor VIII)IBA 02/2011 - 07/2004
2	SMARCB1 ProteinIBA 01/2021 - 09/2014
2	NucleotidesIBA 01/2021 - 01/2018
2	DisintegrinsIBA 01/2018 - 06/2010
2	ThrombospondinsIBA 01/2018 - 06/2010
2	DNA (Deoxyribonucleic Acid)IBA 09/2014 - 02/2013
2	Formaldehyde (Formol)FDA Link 09/2014 - 02/2013
2	Nonsense Codon (Nonsense Mutation)IBA 06/2011 - 02/2010
2	Adenosine Triphosphatases (ATPase)IBA 06/2011 - 02/2010
2	ADAMTS13 ProteinIBA 03/2010 - 03/2003
1	VaccinesIBA 10/2021
1	LigandsIBA 10/2021
1	Peptides (Polypeptides)IBA 10/2021
1	selinexorIBA 01/2021
1	DNA Transposable Elements (Element, IS)IBA 01/2021
1	Prothrombin (Factor II)IBA 01/2021
1	factor V LeidenIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2017
1	CateninsIBA 12/2016
1	hydrogen sulfite (bisulfite)IBA 03/2016
1	ChromatinIBA 03/2016
1	Complement System Proteins (Complement)IBA 12/2014
1	Sucrose (Saccharose)IBA 09/2014
1	HepcidinsIBA 03/2013
1	Erythropoietin FDA Link 03/2013
1	Serine Proteases (Serine Protease)IBA 03/2013
1	ParaffinIBA 02/2013
1	Adenosine Triphosphate (ATP)IBA 02/2010
1	Mucin-1 (CA 15-3 Antigen)IBA 12/2009
1	Inosine Triphosphate (ITP)IBA 03/2003

Therapy/Procedure

4	Ligation 01/2018 - 09/2014
3	Therapeutics 09/2014 - 12/2009
1	Drug Therapy (Chemotherapy) 06/2016
1	Cesarean Section (Caesarean Section) 12/2006